EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023–2024

Jolein Gyonne Elise Laumen iD, Vu N Hieu iD, Pham Hong Nhung iD, Koen Vandelannoote iD, Tam Thi Nguyen iD, Trang T Nguyen iD, Diep T N Nguyen iD, Thomas Kesteman iD, H Rogier van Doorn iD, Tran M Chau, Paul C Adamson iD

The Journal of Infectious Diseases · 30.07.2025 · 232 (1) · e73-e77

DOI: 10.1093/infdis/jiaf071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 12.02.2025. Verfasst von Jolein Gyonne Elise Laumen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Bacterial Phylogenomics Group, Pasteur Institute of Cambodia, Phnom Penh, Cambodia. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Ceftriaxone, Gonorrhea, Anti-Bacterial Agents. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FIC NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ceftriaxone resistance in Neisseria gonorrhoeae is an escalating global health concern, threatening the efficacy of empiric treatment. In the Asia-Pacific region, a rapid surge in ceftriaxone resistance has been observed, primarily associated with the penA-60.001 allele. This study, conducted in Hanoi, Vietnam between 2023 and 2024, analyzed 352 N. gonorrhoeae isolates and found a 27% prevalence of ceftriaxone resistance. Whole-genome sequencing identified that resistance was predominantly driven by the mosaic penA-237.001 allele, with a smaller contribution from penA-60.001. The high prevalence of resistance and the emergence of new alleles underscore the urgent threat to ceftriaxone as an empiric treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeCeftriaxoneGonorrheaAnti-Bacterial AgentsDrug Resistance, BacterialVietnamHumansPrevalenceWhole Genome SequencingMicrobial Sensitivity TestsMaleFemaleAdult

Stichwörter der Autor:innen

Asia, Southeasternantimicrobial resistanceceftriaxonegonorrheawhole-genome sequencing

Substanzen

CeftriaxoneAnti-Bacterial Agents

Autor:innen und Institutionen

  • Bacterial Phylogenomics Group, Pasteur Institute of Cambodia, Phnom Penh, Cambodia.
  • Department of Microbiology, Hanoi Medical University, Hanoi, Vietnam.
  • Department of Microbiology and Parasitology, Hanoi Medical University Hospital, Hanoi, Vietnam.
  • Department of Microbiology, Bach Mai Hospital, Hanoi, Vietnam.
  • Oxford University Clinical Research Unit, Hanoi, Vietnam.
  • Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

ORCID-Profile: Jolein Gyonne Elise Laumen, Vu N Hieu, Pham Hong Nhung, Koen Vandelannoote, Tam Thi Nguyen, Trang T Nguyen, Diep T N Nguyen, Thomas Kesteman, H Rogier van Doorn, Paul C Adamson

Förderung

  • FIC NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Fogarty International Center

Zitieren

APA

Laumen, J. G. E., Hieu, V. N., Nhung, P. H., Vandelannoote, K., Nguyen, T. T., Nguyen, T. T., Nguyen, D. T. N., Kesteman, T., van Doorn, H. R., Chau, T. M., & Adamson, P. C. (2025). High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023–2024. The Journal of Infectious Diseases, 232(1), e73-e77. https://doi.org/10.1093/infdis/jiaf071

Vancouver

Laumen JGE, Hieu VN, Nhung PH, Vandelannoote K, Nguyen TT, Nguyen TT, et al. High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023–2024. The Journal of Infectious Diseases. 2025;232(1):e73-e77. doi:10.1093/infdis/jiaf071

BibTeX
@article{Laumen2025,
  author = {Laumen, Jolein Gyonne Elise and Hieu, Vu N and Nhung, Pham Hong and Vandelannoote, Koen and Nguyen, Tam Thi and Nguyen, Trang T and Nguyen, Diep T N and Kesteman, Thomas and van Doorn, H Rogier and Chau, Tran M and Adamson, Paul C},
  title = {High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023–2024},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {232},
  number = {1},
  pages = {e73--e77},
  doi = {10.1093/infdis/jiaf071}
}
Kostenlos starten →